AKT1 and neoplasm: ADORA2A-AS1 exerts tumor-suppressive roles in HCC via competitively binding HuR, decreasing the binding of HuR to FSCN1 transcript, downregulating FSCN1 transcript stability, repressing FSCN1 expression, and repressing AKT pathway.